Geneos Wealth Management Inc. Reduces Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Geneos Wealth Management Inc. reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,588 shares of the medical equipment provider’s stock after selling 225 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Intuitive Surgical were worth $829,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in ISRG. Mirador Capital Partners LP increased its holdings in Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after buying an additional 50 shares during the last quarter. M.E. Allison & CO. Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $449,000. Seilern Investment Management Ltd bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $82,517,000. Exome Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after buying an additional 1,069 shares during the period. Finally, Consolidated Planning Corp grew its position in shares of Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after buying an additional 1,198 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 1.8 %

Shares of Intuitive Surgical stock opened at $573.48 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The firm has a market capitalization of $204.26 billion, a PE ratio of 92.20, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The stock’s fifty day moving average is $547.16 and its 200-day moving average is $505.21.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of research reports. Raymond James lifted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday. Leerink Partners increased their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday. Evercore ISI boosted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, Piper Sandler reissued an “overweight” rating and set a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research note on Friday. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $613.10.

Insiders Place Their Bets

In other Intuitive Surgical news, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. The trade was a 42.84 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 42,265 shares of company stock worth $21,964,281. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.